Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ezetimibe Tablets bulk supplier for pharma manufacturers

Ezetimibe Tablets 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg

Reference Brands: Zetia (US), Ezetrol (EU)

Category: Heart Disorder

Ezetimibe Tablet is a medicine that is used for the treatment of High Cholesterol Level and other conditions. Ezetimibe Tablet contains Ezetimibe as an active ingredient. Ezetimibe Tablet works by inhibiting the absorption of cholesterol in the intestine.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ezetimibe Tablets? List it or send an offer →

Product Description: Ezetimibe Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · High Cholesterol Level Ezetimibe Tablet Working, Mechanism of Action and Pharmacology Ezetimibe Tablet improves the patient's condition by performing the following functions: · Inhibiting the absorption of cholesterol in the intestine.

Ezetimibe Tablets — third party manufacturing & bulk supply

Ezetimibe Tablets 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ezetimibe Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ezetimibe Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ezetimibe Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ezetimibe Tablets is listed as Tablets in 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ezetimibe Tablets is referenced against Zetia (US), Ezetrol (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Atorvastatin 40mg Tablets

Strength:
40mg

Form: Tablets

Reference Brands: Lipitor(USA), Atorva (India), Zarator (LATAM)

View Details
Indapamide Tablets

Strength:
1.5 mg ,2.5 mg

Form: Tablets

Reference Brands: Lozol (US), Natrilix (EU)

View Details
Isosorbide Mononitrate Tablets

Strength:
10mg, 20mg, 30mg, 60mg

Form: Tablets

Reference Brands: Imdur, Monoket (US)

View Details
Metoprolol Tablets

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Toprol-XL (USA), Betaloc (EU), Metpure (India)

View Details
Ezetimibe / Atorvastatin

Strength:
10/10 mg, 10/20 mg, 10/40 mg, 10/80 mg

Form: Tablets

Reference Brands: Liptruzet (USA), Atozet (EU), Aztor EZ (India)

View Details
Mexiletine Hydrochloride

Strength:
100 mg, 200mg

Form: Capsules

Reference Brands: Mexitil (USA/EU)

View Details
Midodrine Hydrochloride

Strength:
2.5 mg, 5 mg, 10 mg

Form: Tablets

Reference Brands: ProAmatine (USA/EU)

View Details
Milrinone Lactate

Strength:
1 mg/ml, 5mg/ml

Form: Injection

Reference Brands: Primacor (USA/EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us